Microvascular Disease Burden in Type 2 Diabetes

July 18, 2016

Does microvascular disease burden predict future cardiovascular events in type 2 diabetes? Dr. Bobby Lazzara discusses this question.

In this Medical News Minute, developed exclusively for Endocrinology Network, Dr. Bobby Lazzara reviews a cohort study examining the effect of microvascular disease burden on future cardiovascular events in type 2 diabetes. Researchers looked at the cumulative burden of retinopathy, nephropathy, and peripheral neuropathy in over 49,000 patients with type 2 diabetes.